南京科佰生物科技有限公司官方网站欢迎您的光临!
免费咨询热线: 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
HCC1395(人乳腺癌细胞)
CBP60370 | |
I. General information | |
Synonyms: | HCC1395 |
Background: | This cell line was initiated on 12/14/94 from a patient with a family history of cancer (patient's mother had breast cancer). The cell line took 14 months to establish. |
Species: | Homo sapiens, human |
Tissue: | mammary gland; breast/duct |
Disease: | TNM stage I, grade 3, primary ductal carcinoma |
Gender: | female,43 years adult, Caucasian, White |
Morphology: | epithelial |
Growth Mode: | adherent |
DNA Profile: | Amelogenin: X CSF1PO: 11 D13S317: 9 D16S539: 11 D5S818: 11 D7S820: 10,12 THO1: 9.3 TPOX: 11 vWA: 15 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+20%FBS HCC1395完全培养基,# CBP60370M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Receptor Expression: | estrogen receptor, negative according to depositor progesterone receptor, negative |
Oncogene: | her2/neu -, p53 + |
Genes Expressed: | Epithelial glycoprotein 2 (EGP2),cytokeratin 19 |
Cellular Products: | Epithelial glycoprotein 2 (EGP2) cytokeratin 19 |
Comments: | The tumor was classified as TNM stage I, grade 3, invasive ductal carcinoma with 0 out of 34 lymph node metastasis. The cells are poorly differentiated and vacuolated. The cells are negative for expression of Her2-neu but positive for expression of p53. HCC1395 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19. The cells are negative for expression of estrogen receptors (ER -) according to depositor and negative for expression of progesterone receptors (PR -). An EBV transformed lymphoblastoid cell line (HCC1395BL) from the same patient is available as ATCC CRL-2325. For more information, please contact Cobioer (4008-750-250). |
扫一扫,关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号